Lawrence Wilson

The 340B Drug Pricing Program was started to help safety-net providers, yet it fueled health system consolidation. Some lawmakers want to see it reformed.

A study found that some hospitals frequently sued patients for medical debt over a 15-year period, although some providers say billing practices have changed.

Some lawmakers want to breathe new life into an old idea by expanding the use of Health Savings Accounts.

By transitioning the policy from an executive initiative to federal law, a future president could not simply overturn it with an executive order.

The president called for Congress to enact his Most Favored Nation price policy to set prescription drug prices in line with other developed countries.

Surprise bills, unexplained charges, and a lack of price transparency adds stress to patients’ recoveries and makes some leery of seeking further care.

Securities and Exchange Commission records, earnings calls, and public statements show the term and scope of most favored nation deals.

Despite persistent effort from both major parties, disagreement continues over the role of government in providing health care.

Patients may be charged more than 2,000 percent more for the same drug at the same hospital. Researchers say price transparency is the key to change.

The 340B Drug Pricing Program was started to help safety-net providers, yet it fueled health system consolidation. Some lawmakers want to see it reformed.

A study found that some hospitals frequently sued patients for medical debt over a 15-year period, although some providers say billing practices have changed.

Some lawmakers want to breathe new life into an old idea by expanding the use of Health Savings Accounts.

By transitioning the policy from an executive initiative to federal law, a future president could not simply overturn it with an executive order.

The president called for Congress to enact his Most Favored Nation price policy to set prescription drug prices in line with other developed countries.

Surprise bills, unexplained charges, and a lack of price transparency adds stress to patients’ recoveries and makes some leery of seeking further care.

Securities and Exchange Commission records, earnings calls, and public statements show the term and scope of most favored nation deals.

Despite persistent effort from both major parties, disagreement continues over the role of government in providing health care.

Patients may be charged more than 2,000 percent more for the same drug at the same hospital. Researchers say price transparency is the key to change.